Form 4 for BCDA BioCardia, Inc.
Accepted 2023-06-26 00:00:00 ET · period of report 2023-06-23 · accession 0001437749-23-018552 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-26 | 2023-06-23 | BCDA | McClung David | CFO | A - Grant | $2.34 | +4,280 | 135.7K | +3% | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-23 | A | A | 4,280 | $2.34 | 135,724 | D | — | — | (F1) These shares were purchased from the issuer in a registered direct offering that closed on June 23, 2023. |